Clinical Watch: December 2018

January 7, 2019

In this issue of Clinical Watch, we describe expanded uses of Hemlibra® and suggest criteria for the use of Dupixent® to treat severe asthma. We also review a study evaluating factors associated with non-adherence to essential chronic medications. Lastly, we review the prevalence of opioid polypharmacy in two Medicaid pharmacy programs.

For more information about our solutions, please visit

No Previous Flipbooks

Next Flipbook
Clinical Watch: November 2018
Clinical Watch: November 2018

In October 2018, the FDA approved an expanded indication of the HPV vaccine Gardasil 9® to include females ...